HA5-59817-13610
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 571 / SD
- Registered
- 2021-11-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-11-24
Registered in v-safe
-
2021-11-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-08
- 2021-12-15
-
2021-12-24
Survey response — day 28, dose 3MedDRA: Cough, Sinus congestion — Feeling: GoodFree text: Congested sinus, coughMedDRA releases: 2024-11 · check-in free text available
- 2021-12-29
- 2022-01-05
-
2022-02-23
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-05-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | No |
| 2 | 2021-04-19 | Pfizer-BioNTech | No |
| 3 | 2021-11-24 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 28, dose 3
Symptoms: Congested sinus, cough
Release 11 — 3 months, dose 3
Symptoms: Runny nose, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release